Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug-resistance Testing in Kenya to Improve ART Suppression of HIV Replication

NCT01898754 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01898754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug-resistance Testing in Kenya to Improve ART Suppression of HIV Replication
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2013
Completion date
February 28, 2017
Enrollment
991 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv positive